Archi Indonesia Tbk vs Ikapharmindo Putramas Tbk. — how do they compare? Archi Indonesia Tbk trades at Rp1,215 (market cap 30.28T, 11.53M 24h volume), while Ikapharmindo Putramas Tbk. trades at Rp197 (market cap 330.19B, 155.4K 24h volume). The key difference: Archi Indonesia Tbk is far larger — about 91.7× Ikapharmindo Putramas Tbk.'s market cap, and Archi Indonesia Tbk is more actively traded (11.53M versus 155.4K). Which is the better fit depends on your goals.
| ARCI | IKPM | |
|---|---|---|
Market Cap | 30.28T | 330.19B |
Volume | 11.53M | 155.4K |
Lot | 115.29K | 1.55K |
Turnover | 13.83B | 30.61M |
Average Price | 1,199.64 | 196.96 |
Value | 13.83B | 30.61M |
Indicative Equilibrium Price | 1,180 | 195 |
Indicative Equilibrium Volume | 3.67K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Archi Indonesia Tbk. (the Company) was established based on Notarial Deed No. 1 of Fatma Agung Budiwijaya, S.H., dated September 14, 2010. The Company commenced its commercial operations in 2010 and is primarily involved in investment holding. PT Rajawali Corpora is the Companys parent and ultimate parent entity.
Read more on ARCI →PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →